Aptima HPV messenger RNA testing and histopathologic follow‐up in women with HSIL cytology: A study emphasizing additional review of HPV‐negative cases-Reference-Cited by-同舟云学术

Aptima HPV messenger RNA testing and histopathologic follow‐up in women with HSIL cytology: A study emphasizing additional review of HPV‐negative cases

Published:2021-03-25 Issue:8 Volume:129 Page:622-631
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathol

Author:

Li Aofei¹,Li Juan¹²,Austin R. Marshall¹,Wang Tiannan¹³,Ashman Dayne¹⁴^ORCID,Zhang Huina¹⁵,Matsko Jonee¹,Zhao Chengquan¹^ORCID

Affiliation:

1. Department of Pathology Magee‐Womens Hospital, University of Pittsburgh Medical Center Pittsburgh Pennsylvania

2. Jinan Maternity and Child Care Hospital Jinan China

3. Department of Pathology University of Southern California Los Angeles California

4. Department of Pathology University Hospitals Cleveland Medical CenterCase Western Reserve University School of Medicine Cleveland Ohio

5. Department of Pathology University of Rochester Medical Center Rochester New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22421

Reference35 articles.

1. Screening and cervical cancer cure: population based cohort study

2. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study

3. Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

4. APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compliance Rate With Triage Test and Treatment for Participants Screening Positive in Cervical Cancer Screening Programs;Obstetrics & Gynecology;2024-09-12

2. Influence of cervical treatment methods on subsequent vaginal lesions: A study of HPV-related neoplasia;Biomolecules and Biomedicine;2024-05-21

3. Prevalence of cervical precancers or cancers in women with ASC-H/HSIL cytology according to Aptima HPV (AHPV) assay-detected HPV genotypes and age;Journal of Cancer;2024

4. Changes over time in papanicolaou cytology test and HPV test in a large women’s academic center laboratory;Journal of the American Society of Cytopathology;2023-07

5. High‐grade squamous intraepithelial lesion cervicovaginal paps with negative high‐risk HPV testing, a prospective study with histological follow‐up;Diagnostic Cytopathology;2023-04-22